Oppenheimer Holdings Stock News

Synlogic Inc (NASDAQ:SYBX), a clinical-stage company bringing the transformative potential of synthetic biology to medicine, stock fell 1.52% (As on Nov 26, 10:46:42 AM UTC-4,… The post Synlogic Inc (NASDAQ:SYBX) Upgraded by Oppenheimer to Outperform appeared first on FXDailyReport.Com .

Medtronic (NYSE:MDT) had its target price reduced by analysts at Oppenheimer from $150.00 to $145.00 in a report issued on Wednesday, The Fly reports. The brokerage presently has an outperform rating on the medical technology companys stock. Oppenheimers target price points to a potential upside of 26.70% from the companys current price. Oppenheimer also issued []

Marvell Technology (NASDAQ:MRVL) had its target price raised by Oppenheimer from $75.00 to $100.00 in a report released on Tuesday, Analyst Price Targets reports. They currently have an outperform rating on the semiconductor companys stock. A number of other equities analysts also recently commented on MRVL. Jefferies Financial Group lifted their target price on Marvell []

Oppenheimer (NYSE: OPY) is one of 53 publicly-traded companies in the Security brokers & dealers industry, but how does it weigh in compared to its rivals? We will compare Oppenheimer to related companies based on the strength of its analyst recommendations, institutional ownership, risk, dividends, earnings, valuation and profitability. Dividends Oppenheimer pays an annual dividend []

BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target lifted by Oppenheimer from $84.00 to $95.00 in a research report report published on Monday, The Fly reports. The firm currently has a market perform rating on the biotechnology companys stock. Oppenheimer also issued estimates for BioMarin Pharmaceuticals Q4 2021 earnings at ($0.10) EPS, Q1 2022 earnings at []

XPO Logistics, Inc. (NYSE:XPO) Equities researchers at Oppenheimer issued their Q4 2022 earnings per share (EPS) estimates for shares of XPO Logistics in a research report issued to clients and investors on Sunday, November 21st. Oppenheimer analyst S. Schneeberger forecasts that the transportation company will post earnings per share of $0.97 for the quarter. []

Enanta Pharmaceuticals (NASDAQ:ENTA) had its target price upped by Oppenheimer from $55.00 to $73.00 in a research report released on Wednesday morning, The Fly reports. The firm currently has a market perform rating on the biotechnology companys stock. A number of other analysts have also weighed in on the stock. JMP Securities increased their price []

XPO Logistics (NYSE:XPO) had its price target cut by Oppenheimer from $108.00 to $96.00 in a research note published on Monday morning, The Fly reports. They currently have an outperform rating on the transportation companys stock. Oppenheimer also issued estimates for XPO Logistics Q4 2021 earnings at $0.96 EPS, FY2021 earnings at $4.18 EPS, Q1 []

XPO Logistics, Inc. (NYSE:XPO) – Analysts at Oppenheimer issued their Q4 2022 earnings per share estimates for shares of XPO Logistics in a research note issued to investors on Sunday, November 21st. Oppenheimer analyst S. Schneeberger expects that the transportation company will post earnings per share of $0.97 for the quarter. Oppenheimer currently has a […]

Semtech Co. (NASDAQ:SMTC) Analysts at Oppenheimer boosted their Q3 2022 earnings per share estimates for Semtech in a research report issued on Monday, November 22nd. Oppenheimer analyst R. Schafer now expects that the semiconductor company will post earnings of $0.52 per share for the quarter, up from their previous forecast of $0.49. Oppenheimer currently []

CNBC Television published this video item, entitled Oppenheimers Read more

PennantPark Floating Rate Capital Ltd. (NASDAQ:PFLT) Equities researchers at Oppenheimer issued their Q1 2023 earnings estimates for PennantPark Floating Rate Capital in a report released on Thursday, November 18th. Oppenheimer analyst M. Penn expects that the asset manager will post earnings per share of $0.28 for the quarter. Oppenheimer also issued estimates for PennantPark []

John Stoltzfus, CIO of Oppenheimer. Oppenheimer Co. Oppenheimer''s John…

CYBIN INC. (CYBN.NE) (OTCMKTS:CYBN) had its target price hoisted by equities researchers at HC Wainwright from $8.00 to $10.00 in a note issued to investors on Monday, The Fly reports. The brokerage currently has a buy rating on the stock. CYBN has been the subject of a number of other reports. Oppenheimer started coverage on []